In progress
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Work plan
Work plan
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Chemicals
- First and second generation anticoagulant rodenticides
Review period
Timeframe calculation pursuant to Regulation 78B of the Agricultural and Veterinary Chemicals Code Regulations 1995A + B + 2E + 3C + J + D + X = 42 months
A = 13 months (Environment – level 1)
B = 13 months (Health – level 1)
C = 3 months (Finalisation – type 1)
D = 4 months
E = 0 months
J = 3 months (consultation with jurisdictional coordinator)
X = 0 months (in any other case)
1. Nomination
1. Nomination
Phase status
CompletedAnticoagulant rodenticides; warfarin, coumatetralyl, diphacinone, brodifacoum, bromadiolone, difenacoum, difethialone, and flocoumafen, were nominated for review and prioritised for consideration on the basis of public health, worker safety and environmental safety.
2. Prioritisation
2. Prioritisation
Phase status
Completed
3. Scoping and work plan
3. Scoping and work plan
Phase status
Completed
4. Notice of reconsideration
4. Notice of reconsideration
Phase status
CompletedNotice of the reconsideration of anticoagulant rodenticides under section 32(1) of the Agvet Code was sent to affected holders of product registrations and label approvals, and active constituent approvals on 2 November 2021. Notice of the reconsideration was also published in the APVMA Gazette of 2 November 2021 and included details on how to submit information to be considered as part of the reconsideration.
The period for submission of information to be assessed under this reconsideration closed on 2 February 2022.
The reconsideration is now in the assessment phase.
An s 33 notice was sent to a holder on 28 November 2022 to request additional data.
5. Assessment
5. Assessment
Phase status
In ProgressThe statutory period for assessments to be completed is 26 months.
When the component risk assessments have been completed, the proposed regulatory decisions will be drafted.
6. Proposed regulatory decision
6. Proposed regulatory decision
Phase status
ForecastedPublication of the proposed regulatory decision is expected in September 2024.
7. Consultation
7. Consultation
Phase status
ForecastedA statutory period of 3 months for public consultation will follow publication of the proposed regulatory decision.
8. Regulatory decision
8. Regulatory decision
Phase status
ForecastedFollowing the close of the public consultation period on the proposed regulatory decision, and consideration of submissions received, the final regulatory decision will be published.
Publication of the final regulatory decision is expected in July 2025.
9. Implementation
9. Implementation
Phase status
ForecastedThe implementation period will begin on the date the final regulatory decision is made.
Publication archive
Publication Archive
| Type | Title | Publication date |
|---|---|---|
| Public consultation | Submissions received in response to 2020 public consultation | 2 November 2021 |
| Work plan | 2 November 2021 | |
| Gazette | Notice of reconsideration | 2 November 2021 |